PMC:7696151 / 112952-113283 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"4083","span":{"begin":89,"end":97},"obj":"Species"},{"id":"4084","span":{"begin":196,"end":204},"obj":"Species"},{"id":"4085","span":{"begin":284,"end":292},"obj":"Species"},{"id":"4086","span":{"begin":317,"end":326},"obj":"Species"},{"id":"4145","span":{"begin":110,"end":113},"obj":"Chemical"},{"id":"4146","span":{"begin":135,"end":138},"obj":"Chemical"},{"id":"4202","span":{"begin":71,"end":79},"obj":"Disease"},{"id":"4203","span":{"begin":80,"end":88},"obj":"Disease"}],"attributes":[{"id":"A4083","pred":"tao:has_database_id","subj":"4083","obj":"Tax:9606"},{"id":"A4084","pred":"tao:has_database_id","subj":"4084","obj":"Tax:9606"},{"id":"A4085","pred":"tao:has_database_id","subj":"4085","obj":"Tax:9606"},{"id":"A4086","pred":"tao:has_database_id","subj":"4086","obj":"Tax:2697049"},{"id":"A4145","pred":"tao:has_database_id","subj":"4145","obj":"MESH:D006886"},{"id":"A4146","pred":"tao:has_database_id","subj":"4146","obj":"MESH:D017963"},{"id":"A4202","pred":"tao:has_database_id","subj":"4202","obj":"MESH:C000657245"},{"id":"A4203","pred":"tao:has_database_id","subj":"4203","obj":"MESH:D007239"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Molina et al. (2020) [34] Prospective, non-comparative study11 severe COVID-19 infected patients 600 mg/day HCQ per 10 days + 500 mg AZM on day 1 followed by 250 mg/day for 4 days On day 5 two patients were transferred to the ICU.At days 5 to 6, after treatment initiation 8 of 10 patients were still positive for SARS-CoV2 RNA."}

{"project":"LitCovid-sentences","denotations":[{"id":"T763","span":{"begin":0,"end":331},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Molina et al. (2020) [34] Prospective, non-comparative study11 severe COVID-19 infected patients 600 mg/day HCQ per 10 days + 500 mg AZM on day 1 followed by 250 mg/day for 4 days On day 5 two patients were transferred to the ICU.At days 5 to 6, after treatment initiation 8 of 10 patients were still positive for SARS-CoV2 RNA."}